funder-graph

FundersMAAdvanced Medical Research Foundationinc › 2022

Grants paid by Advanced Medical Research Foundationinc, tax year 2022

EIN 51-0209657 · Chestnut Hill, MA · Form 990, Schedule I · NTEE H30

In tax year 2022, Advanced Medical Research Foundationinc (EIN 51-0209657) reported 6 grants paid totaling $7,947,500. Dataset version 2026.09.0, built 2026-09-03.

20192020202220232024

Every grant, 2022

Grants reported by Advanced Medical Research Foundationinc for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Massachusetts General Hospital Boston, MAA$4,966,000paidCANCER RESEARCH (MULTI YEAR GRANT)202413099349302191
2022Massachusetts General Hospital Boston, MAA$1,966,000paidCANCER RESEARCH202322439349300742
2022Children's Hospital Boston Boston, MAA$307,750paidCANCER RESEARCH202413099349302191
2022Children's Hospital Boston Boston, MAA$307,750paidCANCER RESEARCH202322439349300742
2022Whitehead Institute for Biomedical Research Cambridge, MAA$200,000paidCANCER RESEARCH202322439349300742
2022Whitehead Institute for Biomedical Research Cambridge, MAA$200,000paidCANCER RESEARCH202413099349302191

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.